{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:46:24Z","timestamp":1787510784058,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":3053,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.breast.2011.01.006","type":"journal-article","created":{"date-parts":[[2011,2,9]],"date-time":"2011-02-09T04:48:08Z","timestamp":1297226888000},"page":"254-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer"],"prefix":"10.1016","volume":"20","author":[{"given":"Iman","family":"Haroun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aletta","family":"Poll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Weitzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Narod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2011.01.006_bib1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1 mutation carriers","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2011.01.006_bib2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-148-9-200805060-00007","article-title":"Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer","volume":"148","author":"Warner","year":"2008","journal-title":"Ann Int Med"},{"key":"10.1016\/j.breast.2011.01.006_bib3","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/ijc.21536","article-title":"Hereditary breast cancer clinical study group. Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update","volume":"118","author":"Gronwald","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.breast.2011.01.006_bib4","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study","volume":"23","author":"Eisen","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.01.006_bib5","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.01.006_bib6","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","article-title":"Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers","volume":"93","author":"Hartmann","year":"2001","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.breast.2011.01.006_bib7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ejca.2005.11.020","article-title":"Risk-reducing surgery in women with familial susceptibility for breast and\/or ovarian cancer","volume":"42","author":"Antill","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2011.01.006_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1472-6874-10-24","article-title":"Women\u2019s constructions of the \u201cright time\u201d to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy","volume":"10","author":"Howard","year":"2010","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.breast.2011.01.006_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/bmj.322.7278.76","article-title":"The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews","volume":"322","author":"Hatcher","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.breast.2011.01.006_bib10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/01.PRS.0000131877.52740.0E","article-title":"Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: a descriptive study","volume":"114","author":"Metcalfe","year":"2004","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.breast.2011.01.006_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/annonc\/mdm537","article-title":"The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited","volume":"19","author":"Hoogerbrugge","year":"2008","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.breast.2011.01.006_bib12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1200\/JCO.2007.12.6078","article-title":"Predictors of contralateral mastectomy in women with a BRCA1 or BRCA2 mutation: the hereditary breast cancer clinical study group","volume":"26","author":"Metcalfe","year":"2008","journal-title":"JCO"},{"issue":"2","key":"10.1016\/j.breast.2011.01.006_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10897-008-9200-1","article-title":"Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer","volume":"18","author":"Hamilton","year":"2009","journal-title":"J\u00a0Genet Couns"},{"issue":"3","key":"10.1016\/j.breast.2011.01.006_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/0272989X0002000301","article-title":"Prophylactic mastectomy or screening in women suspected to have the BRCA1\/2 mutation: a prospective pilot study of women\u2019s treatment choices and medical decision-analytic recommendations","volume":"20","author":"Unic","year":"2000","journal-title":"Med Decis Making"},{"issue":"11","key":"10.1016\/j.breast.2011.01.006_bib15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3816\/CBC.2007.n.053","article-title":"Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers","volume":"7","author":"Friebel","year":"2007","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2011.01.006_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1472-6874-7-3","article-title":"Time to decide about risk-reducing mastectomy: a case series of BRCA1\/2 gene mutation carriers","volume":"7","author":"McCullum","year":"2007","journal-title":"BMC Womens Health"},{"issue":"11","key":"10.1016\/j.breast.2011.01.006_bib17","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2011.01.006_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1524-4741.2009.00857.x","article-title":"Breast cancer prevention: patient decision making and risk communication in the high risk setting","volume":"16","author":"Ozanne","year":"2010","journal-title":"Breast J"},{"issue":"2","key":"10.1016\/j.breast.2011.01.006_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pec.2008.05.010","article-title":"Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs","volume":"73","author":"Zikmund-Fisher","year":"2008","journal-title":"Patient Educ Couns"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977611000099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977611000099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:27:34Z","timestamp":1760776054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977611000099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0960977611000099"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2011.01.006","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2011.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}